A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

Clinical trial NCT00618124 · COMPLETED

Trial details

NCT number: NCT00618124
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Breast Cancer Neoplasms

Start date: 2005-05-01
Primary completion: 2008-07-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.